
Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion deal.
Poseida Therapeutics shares jumped 218.8% to $9.12 in the pre-market trading session.